XML 64 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Shareholders’ Equity and Redeemable Noncontrolling Interest (unaudited) - USD ($)
Total
Common Stock
Deferred Equity Compensation
Retained Earnings
Beginning balance (shares) at Dec. 31, 2018   3,499,285    
Beginning Balance at Dec. 31, 2018 $ 195,575,943 $ 124,933,060 $ (22,008,054) $ 92,650,937
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (shares)   24,875    
Issuance of restricted stock grants   $ 3,859,300 (3,859,300)  
Amortization of restricted stock grants 1,521,974   1,521,974  
Issuance of stock grants (in shares)   24,048    
Issuance of stock grants 3,655,296 $ 3,655,296    
Issuance of common stock related to 401k plan match (in shares)   4,286    
Issuance of common stock related to 401k plan match 632,050 $ 632,050    
Forfeiture of restricted stock grants (shares)   (4,250)    
Forfeiture of restricted stock grants   $ (688,606) 688,606  
Repurchase of common stock (shares)   (53,645)    
Repurchase of common stock (7,907,055) $ (7,907,055)    
Net income 16,932,642     16,932,642
Ending balance (shares) at Mar. 31, 2019   3,494,599    
Ending Balance at Mar. 31, 2019 210,410,850 $ 124,484,045 (23,656,774) 109,583,579
Beginning balance attributable to redeemable noncontrolling Interests at Dec. 31, 2018 62,679,687      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Net Income Attributable to Redeemable Noncontrolling Interest (2,623,205)      
Net subscriptions of consolidated funds (1,728,877)      
Net consolidations (deconsolidations) of Company sponsored investments (27,324,561)      
Ending balance attributable to redeemable noncontrolling Interests at Mar. 31, 2019 $ 36,249,454      
Beginning balance (shares) at Dec. 31, 2019 3,470,428 3,294,672    
Beginning Balance at Dec. 31, 2019 $ 192,855,681 $ 95,853,477 (20,331,890) 117,334,094
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of restricted stock grants (shares)   3,850    
Issuance of restricted stock grants   $ 347,424 (347,424)  
Amortization of restricted stock grants 1,786,217   1,786,217  
Issuance of stock grants (in shares)   23,640    
Issuance of stock grants 3,396,359 $ 3,396,359    
Issuance of common stock related to 401k plan match (in shares)   5,316    
Issuance of common stock related to 401k plan match 647,100 $ 647,100    
Shares withheld related to employee tax withholding (in shares)   (1,801)    
Shares withheld related to employee tax withholding (252,968) $ (252,968)    
Forfeiture of restricted stock grants (shares)   (1,225)    
Forfeiture of restricted stock grants   $ (206,347) 206,347  
Repurchase of common stock (9,182,577) $ (9,182,577)    
Net income $ 1,530,108     1,530,108
Ending balance (shares) at Mar. 31, 2020 3,247,515 3,247,515    
Ending Balance at Mar. 31, 2020 $ 190,779,920 $ 90,602,468 $ (18,686,750) $ 118,864,202
Beginning balance attributable to redeemable noncontrolling Interests at Dec. 31, 2019 14,178,824      
Increase (Decrease) in Temporary Equity [Roll Forward]        
Net Income Attributable to Redeemable Noncontrolling Interest 4,058,476      
Net subscriptions of consolidated funds (565,998)      
Ending balance attributable to redeemable noncontrolling Interests at Mar. 31, 2020 $ 9,554,350